7 Major Markets Opioid Withdrawal Syndrome Epidemiology Forecasts 2020-2024 & 2034 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.

The report delivers an in-depth understanding of Opioid Withdrawal Syndrome, historical and forecasted epidemiology of Opioid Withdrawal Syndrome in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

As the market is derived using the patient-based model, the Opioid Withdrawal Syndrome epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Number of Opioid misuse cases, Number of cases with long-term opioid usage, and Total Opioid Withdrawal Syndrome Cases in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain) and the United Kingdom, and Japan, from 2020 to 2034.

KOL Views

To gaze into the epidemiology insights of the real world, we take KOLs and SMEs' opinions working in the domain through primary research to fill the data gaps and validate our secondary research on disease prevalence.

The analysts connected with 20+ KOLs to gather insights; however, interviews were conducted with 10+ KOLs in the 7MM. Centers such as the Texas A&M University, College Station, TX, USA; Baylor College of Medicine, Houston, Texas; University of Southern California, USA; Bremen Institute of Drug Research, University of Bremen, Germany; Meiji Pharmaceutical University, Tokyo and others were contacted. Their opinions help understand and validate current disease prevalence, gender involved with the disease, diagnosis rate, and diagnostic criteria.

Key Highlights

• The analyst projects that the total number of Opioid withdrawal syndrome cases in 7MM were approximately 8,169,411 in 2022 and these cases are further expected to decrease during the forecasted period (2023-2034).
• According to analysis, the total number of opioid misuse cases in the US was found to be 9,264,786 in 2022 and is estimated to decline with a significant CAGR throughout the forecast period (2023-2034).
• In 2022, the total number of cases with long-term opioid usage was 9,077,124 in the 7MM, which is anticipated to decrease during the study period [2020-2034].
• According to estimates, the US alone accounted for 85% of the total Opioid Misuse Cases in the 7MM in 2022.

Scope of the Report

• The report covers a segment of key events, an executive summary, descriptive overview of Opioid Withdrawal Syndrome, explaining its causes, signs and symptoms, and currently available therapies.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, disease progression, and treatment guidelines.
• The report provides an edge for understanding trends, expert insights/KOL views, and patient journeys in the 7MM.
• A detailed review of current challenges in establishing the diagnosis.

Opioid Withdrawal Syndrome Report Insights

• Patient Population
• Country-wise Epidemiology Distribution
• Number of Opioid Misuse cases
• Number of Cases with long-term Opioid Usage
• Total Opioid Withdrawal Syndrome Cases

Opioid Withdrawal Syndrome Report Key Strengths

• 12 years Forecast
• The 7MM Coverage
• Opioid Withdrawal Syndrome Epidemiology Segmentation

Opioid Withdrawal Syndrome Report Assessment

• Current Diagnostic Practices Patient Segmentation 

Key Topics Covered:

1. Key Insights

2. Report Introduction

3. Opioid Withdrawal Syndrome Epidemiology Overview at a Glance

3.1. Patient Share (%) Distribution of OWS in 2020

3.2. Patient Share (%) Distribution of OWS in 2034

4. Epidemiology Methodology of OWS

5. Executive Summary

6. Key Events

7. Opioid Withdrawal Syndrome: Disease Background and Overview

7.1. Introduction

7.2. Etiology

7.3. Pathophysiology

7.4. Diagnosis

7.4.1. Differential Diagnosis

7.4.2. Diagnostic Algorithm

7.4.3. Diagnostic Guidelines

7.4.3.1. DSM-5 Diagnostic Criteria for Opioid Withdrawal

8. Epidemiology and Patient Population

8.1. Key Findings

8.2. Assumptions and Rationale

8.3. Total Opioid Withdrawal Syndrome Cases in the 7MM

8.4. The United States

8.4.1. Number of Opioid Misuse Cases in the US

8.4.2. Number of Long-term Opioid Usage Cases in the US

8.4.3. Total Opioid Withdrawal Syndrome Cases in the US

8.5. EU4 and the UK

8.5.1. Number of Opioid Misuse Cases in EU4 and the UK

8.5.2. Number of Long-term Opioid Usage Cases in EU4 and the UK

8.5.3. Total Opioid Withdrawal Syndrome Cases in EU4 and the UK

8.6. Japan

8.6.1. Number of Opioid Misuse Cases in Japan

8.6.2. Number of Long-term Opioid Usage Cases in Japan

8.6.3. Total Opioid Withdrawal Syndrome Cases in Japan

9. Patient Journey

10 . Key Opinion Leaders' Views

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/h1u861

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.